Cargando…
Protein-coated corrole nanoparticles for the treatment of prostate cancer cells
Development of novel therapeutic strategies to eradicate malignant tumors is of paramount importance in cancer research. In a recent study, we have introduced a facile protocol for the preparation of corrole-protein nanoparticles (NPs). These NPs consist of a corrole-core coated with protein. We now...
Autores principales: | Soll, Matan, Chen, Qiu-Cheng, Zhitomirsky, Benny, Lim, Punnajit P., Termini, John, Gray, Harry B., Assaraf, Yehuda G., Gross, Zeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387447/ https://www.ncbi.nlm.nih.gov/pubmed/32793397 http://dx.doi.org/10.1038/s41420-020-0288-x |
Ejemplares similares
-
Cell-Penetrating Protein/Corrole Nanoparticles
por: Soll, Matan, et al.
Publicado: (2019) -
Corrole
Nanoparticles for Chemotherapy of Castration-Resistant
Prostate Cancer and as Sonodynamic Agents for Pancreatic Cancer Treatment
por: Soll, Matan, et al.
Publicado: (2022) -
Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
por: Zhitomirsky, Benny, et al.
Publicado: (2014) -
Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis
por: Zhitomirsky, Benny, et al.
Publicado: (2017) -
Correction: Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
por: Zhitomirsky, Benny, et al.
Publicado: (2022)